IMMUNE PHARMACEUTICALS INC's ticker is IMNPQ and the CUSIP is 45254C200. A total of 14 filers reported holding IMMUNE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $7,000 | – | 11,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 24,681 | $14,000 | 0.00% |
| VANGUARD GROUP INC | 415,518 | $237,000 | 0.00% |
| UBS Group AG | 87,514 | $50,000 | 0.00% |
| Advisor Group, Inc. | 3,750 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 21,594 | $12,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 22,355 | $12,000 | 0.00% |
| DEUTSCHE BANK AG\ | 4 | $0 | 0.00% |
| CREDIT SUISSE AG/ | 23,504 | $14,000 | 0.00% |
| MORGAN STANLEY | 54 | $0 | 0.00% |
| BlackRock Inc. | 568 | $0 | 0.00% |